200 related articles for article (PubMed ID: 22792175)
1. Cooperative interaction between the MUC1-C oncoprotein and the Rab31 GTPase in estrogen receptor-positive breast cancer cells.
Jin C; Rajabi H; Pitroda S; Li A; Kharbanda A; Weichselbaum R; Kufe D
PLoS One; 2012; 7(7):e39432. PubMed ID: 22792175
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
Kharbanda A; Rajabi H; Jin C; Raina D; Kufe D
Mol Cancer Res; 2013 Jul; 11(7):714-23. PubMed ID: 23538857
[TBL] [Abstract][Full Text] [Related]
3. MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.
Wei X; Xu H; Kufe D
Mol Cell; 2006 Jan; 21(2):295-305. PubMed ID: 16427018
[TBL] [Abstract][Full Text] [Related]
4. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
[TBL] [Abstract][Full Text] [Related]
5. Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells.
Grismayer B; Sölch S; Seubert B; Kirchner T; Schäfer S; Baretton G; Schmitt M; Luther T; Krüger A; Kotzsch M; Magdolen V
Mol Cancer; 2012 Aug; 11():62. PubMed ID: 22920728
[TBL] [Abstract][Full Text] [Related]
6. Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.
Khodarev N; Ahmad R; Rajabi H; Pitroda S; Kufe T; McClary C; Joshi MD; MacDermed D; Weichselbaum R; Kufe D
Oncogene; 2010 Feb; 29(6):920-9. PubMed ID: 19915608
[TBL] [Abstract][Full Text] [Related]
7. Inverse association of rab31 and mucin-1 (CA15-3) antigen levels in estrogen receptor-positive (ER+) breast cancer tissues with clinicopathological parameters and patients' prognosis.
Kotzsch M; Kirchner T; Soelch S; Schäfer S; Friedrich K; Baretton G; Magdolen V; Luther T
Am J Cancer Res; 2017; 7(9):1959-1970. PubMed ID: 28979817
[TBL] [Abstract][Full Text] [Related]
8. Targeting the intracellular MUC1 C-terminal domain inhibits proliferation and estrogen receptor transcriptional activity in lung adenocarcinoma cells.
Klinge CM; Radde BN; Imbert-Fernandez Y; Teng Y; Ivanova MM; Abner SM; Martin AL
Mol Cancer Ther; 2011 Nov; 10(11):2062-71. PubMed ID: 21862684
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7.
Ren L; Marquardt MA; Lech JJ
Chem Biol Interact; 1997 Apr; 104(1):55-64. PubMed ID: 9158695
[TBL] [Abstract][Full Text] [Related]
10. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
Alam M; Rajabi H; Ahmad R; Jin C; Kufe D
Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886
[TBL] [Abstract][Full Text] [Related]
11. The role of the small GTPase Rab31 in cancer.
Chua CE; Tang BL
J Cell Mol Med; 2015 Jan; 19(1):1-10. PubMed ID: 25472813
[TBL] [Abstract][Full Text] [Related]
12. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.
Alam M; Ahmad R; Rajabi H; Kharbanda A; Kufe D
J Biol Chem; 2013 Oct; 288(43):30892-903. PubMed ID: 24043631
[TBL] [Abstract][Full Text] [Related]
13. MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.
Rajabi H; Ahmad R; Jin C; Kosugi M; Alam M; Joshi MD; Kufe D
J Biol Chem; 2012 Mar; 287(13):10703-10713. PubMed ID: 22318732
[TBL] [Abstract][Full Text] [Related]
14. MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer.
Merikhian P; Ghadirian R; Farahmand L; Mansouri S; Majidzadeh-A K
Expert Rev Anticancer Ther; 2017 Jul; 17(7):607-613. PubMed ID: 28597750
[TBL] [Abstract][Full Text] [Related]
15. Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells.
Soelch S; Beaufort N; Loessner D; Kotzsch M; Reuning U; Luther T; Kirchner T; Magdolen V
Mol Med; 2021 Dec; 27(1):158. PubMed ID: 34906074
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer.
Jing X; Liang H; Hao C; Yang X; Cui X
Oncol Rep; 2019 Feb; 41(2):801-810. PubMed ID: 30483806
[TBL] [Abstract][Full Text] [Related]
17. Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor-Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis.
Escher TE; Lui AJ; Geanes ES; Walter KR; Tawfik O; Hagan CR; Lewis-Wambi J
Mol Cancer Res; 2019 May; 17(5):1180-1194. PubMed ID: 30655323
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MUC1 expression by indole-3-carbinol.
Lee IJ; Han F; Baek J; Hisatsune A; Kim KC
Int J Cancer; 2004 May; 109(6):810-6. PubMed ID: 15027113
[TBL] [Abstract][Full Text] [Related]
19. Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein.
Jin C; Rajabi H; Rodrigo CM; Porco JA; Kufe D
Oncogene; 2013 Apr; 32(17):2179-88. PubMed ID: 22689062
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
